Abstract
We investigated the serum concentrations of zinc and copper during the inflammatory process together with the effect of treatment with a nonsteroid anti-inflammatory agent on these trace elements concentrations. In the present study, we used 92 guinea pigs, 12 of which constituted the control group; the remaining 80 were the experimental group. To start with, proquazone (as anti-inflammatory agent) was administered orally to 40 guinea pigs of the experimental group at 20-mg/kg doses 2 h before the surgery. Throughout the experimental period, the above dose was administered to the animals twice a day. We produced inflammation in all animals of the experimental group by using carrageenan (inflammatory agent) dropped into mandibular surgical defects. Serum concentrations of zinc and copper were determined by atomic absorption spectrophotometry in both groups at the 6th, 48th, 120th, 168th, and 240th h. The serum zinc concentrations of the carrageenan-administered group decreased significantly (p<0.01). When comparing the serum zinc concentrations of the carrageenan plus proquazone-administered group with those of control group, the decrease (p<0.05) at the 6th, 48th, and 120th h were statistically significant. When the copper serum concentrations of the carrageenan-administered group were compared with those of the control group, at the 48th, 120th, and 168th h, a statistically significant increase (p<0.01) was observed. However, there was no significant change in the carrageenan plus proquazone-administered group at the 168th and 240th h. As a result during the acute phase of inflammation, serum zinc concentrations decreased, whereas serum copper concentrations increased. The alterations in zinc concentrations were more rapid than those in copper concentrations, but the administration of proquazone slowed the rate of decrease in serum zinc concentrations.
Similar content being viewed by others
References
R. S. Contran, V. Kumar, and S. L. Robbins, Inflammation and repair, (chapter 7), in Robbins Pathologic Basis of Disease, 4th ed., WB Saunders, Philadelphia, pp. 39–86 (1989).
N. S. Rote, Inflammation: Alteration in immunity and inflammation (chapter 8), in: Pathophysiology The Biologic Basis for Disease in Adult and Children, 2nd ed., K. L. McCance and S. E. Huether, eds., Mosby, Baltimore, MD, pp. 234–298 (1994).
R. G. Topozian and M. H. Goldberg, Infection and host, in Management of Infections of the Oral and Maxillofacial Regions, WB Saundes, Philadelphia, pp. 1–38 (1981).
V. J. Pories, J. H. Henzel, C. G. Williams, et al., Acceleration of healing with zinc sulphate, Ann. Surg. 165, 432–436 (1967).
M. W. Greaves and A. W. Skillen, Effect of long continued ingestion of zinc sulphate in patients with venous leg ulceration, Lancet 2 (7679), 889–891 (1970).
W. R. Beisel, Trace elements in infectious processes, Med. Clin. North. Am. 60(4), 831–850 (1976).
A. M. Kahn and H. E. Gordon, Alterations of zinc metabolism following surgical operations, Surg. Gynecol. Obstet. 128, 88–90 (1969).
A. Rahmat, J. N. Norman, and G. Smith, The effect of zinc deficiency on wound healing, Br. J. Surg. 61, 271–273 (1974).
I. Tengrup and H. Samuelson, Changes in serum zinc during and after surgical procedures, Acta Chir. Scand. 143, 195–199 (1977).
R. S. Pekarek, R. W. Wannemacher, and W. R. Beirsel, The effect of leukocytic endogenous mediator (LEM) on the tissue distribution of zinc and iron, Proc. Soc. Exp. Biol. Med. 140, 685–688 (1972).
E. Funseth, U. Lindh, G. Friman, et al., Relation between trace element levels in plasma and myocardium during coxsackievirus B3 myocarditis in the mouse, Biometals 13(4), 361–367 (2000).
F. Rosner and P. C. Gorfien, Erythrocyte and plasma zinc and magnesium levels in health and disease, J. Lab. Clin. Med. 72(2), 213–219 (1968).
Perkin-Elmer, Analysis of serum determination of copper and zinc, in Analytical Method for Atomic Absorption Spectrophotometry, Perkin-Elmer Corp., Norwalk, CT, p. BC-5 (1973).
M. M. Parker, F. L. Humoller, and D. J. Mahler, Determination of copper and zinc in biological materials, Surg. Forum 13, 40–48 (1967).
T. Hallbook and H. Hedelin, Zinc metabolism on surgical trauma, Br. J. Surg. 64, 271–274 (1977).
R. Hallgren, M. Feltelius, and U. Lindh, Redistribution of minerals and trace elements in chronic inflammation: a study on isolated blood cells from patients with ankylosing spondylitis, J. Rheumatol. 14(3), 548–553 (1987).
A. Shenkin, Trace elements and inflammatory response: implications for nutritional support, Nutrition 11(1 Suppl.), 100–105 (1995).
I. Kushner, Regulation of acute phase response by cytokines, Perspect. Biol. Med. 36(4), 611–622 (1993).
R. Milanino, M. Marrella, U. Moretti, et al., Copper and zinc status in rats with acute inflammation: focus on the inflamed area, Agent Actions 24(3–4), 356–364 (1988).
G. Velo, L. Franco, A. Conforti, et al., Ceruloplasmin and copper in inflammation, Eur. J. Rheum. Inflamm. 5(4), 382–385 (1982).
C. L. Braunschweig, M. Sowers, D. S. Kovacevich, et al., Parenteral zinc supplementation in adult humans during the acute phase response increases the febrile response, J. Nutr. 127(1), 70–74 (1997).
J. Yatsuyanagy, I. Kazuhika, and O. Taketa, Suppressive effect of zinc of same functions of neutrophils: studies with carrageenan induced inflammation in rats, Chem. Pharm. Bull. 35(2), 699–704 (1987).
M. C. McGahan, Copper and aspirin treatment increase the antioxidant activity of plasma, Agent Actions 1(1–2), 59–64 (1990)
M. Gorecki, Y. Beck, J. R. Hartman, et al., Recombinant human superoxide dismutases: production and potantial therapeutical uses, Free Radical Res. Commun. 1(12–13), 401–410 (1991).
R. Miesel, H. J. Hartmann, and U. Weser, Antiinflammatory reactivity of copper (1) thionen, Inflammation 14(5), 471–483 (1990).
U. Skaleric C. M. Manthey, S. E. Mergenhagen, et al., Superoxide release and superoxide dismutase expression by human gingival fibroblasts, Eur. J. Oral Sci. 108(2), 130–135 (2000).
M. Corominas, Mechanisms implicated in adverse to non-steroidal anti-inflammatory drugs, Clin. Exp. Allergy 28(4 Suppl.), 41–45 (1998).
J. R. Vane, Introduction mechanism of action of NSAID, Br. J. Rheumatol. 35, 1–3 (1996).
R. S. Spangler, Cyclooxygenase 1 and 2 in rheumatic disease: implications for NSAID drug therapy, Semin. Arthritis Rheum. 26(1), 435–446 (1996).
R. M. Jimenez-Hernandez, D. Frechilla, B. Lasheras, et al., Inhibition of inflammation and gastric damage in rats by copper (II) complexes, Arzneimittelforschung 45(3), 277–281 (1995).
V. Brumas, B. Brumas, and G. G. Berthon, Copper (II) interaction with nonsteroidal antiinflammatory agents (salicylic acid and acetylsalicylic acid), J. Inorg. Biochem. 57(3), 191–207 (1995).
G. Berthon, Is copper pro- or anti-inflammatory? A reconciling view and a novel approach for the use of copper in the control of inflammation, Agents Actions 39(3–4), 210–217 (1993).
M. Roch-Arveiller, D. P. Huy, L. Maman, et al., Nonsterodial anti-inflammatory drug-copper complex modulation of polymorphonuclear leukocyte migration, Biochem. Pharmacol. 39(3), 569–574 (1990).
H. Miche, V. Brumas, and G. Berthon, Copper (II) interactions with nonsteroidal anti-inflammatory agents. II. Anthranilic acid as a potential OH-inactivating ligand, J. Inorg. Biochem. 68(1), 27–38 (1997).
D. Quviy, J. Neve, J. Fontaine, et al., Trace element status and inflammation parameters during chronic indomethacin treatment in adjuvant arthritic rats, Biol. Trace Element Res. 47(1–3), 209–218 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Akçil, E., Yavuz, G. & Koçak, M. Effects of inflammation and anti-inflammatory treatment on serum trace elements concentrations. Biol Trace Elem Res 93, 95–103 (2003). https://doi.org/10.1385/BTER:93:1-3:95
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/BTER:93:1-3:95